Over the past year, many Abbott Laboratories (NYSE:ABT) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions ...

Aristotle Atlantic Core Equity Strategy stated the following regarding Abbott Laboratories (NYSE:ABT) in its Q2 2024 investor letter: "We sold Abbott Laboratories (NYSE:ABT) given the full ...

Over the past year, many Abbott Laboratories (NYSE:ABT) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usually ...

R obert B. Ford (NYSE:F), Chairman and CEO of Abbott Laboratories (NYSE:ABT), recently sold a significant portion of his holdings in the company. According to a Form 4 filing with the Securities ...

Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool has a disclosure policy.

Abbott Laboratories ABT will release earnings results for its third quarter, before the opening bell on Wednesday, Oct. 16. Analysts expect the North Chicago, Illinois-based company to report ...